Loading…
Based on limited metadata from this 2018 FDA Warning Letter, CIGNOT INC received notice of regulatory violations, though the specific subject matter and detailed nature of the violations are not available. The letter was issued on March 29, 2018, and pertains to a product category classified as "Other," which prevents specific identification of the product type or applicable regulatory requirements. Without access to the full letter text or additional details about the issuing FDA office, the precise scope of the violations and remedial actions required cannot be determined from this metadata alone.